Status:
UNKNOWN
A Smartphone-based Intervention for Diabetes Prevention in Overweight Chinese Adults With Pre-diabetes
Lead Sponsor:
The University of Hong Kong
Conditions:
Pre-diabetes
Eligibility:
All Genders
40-60 years
Phase:
NA
Brief Summary
Type 2 diabetes (T2DM) is a serious chronic condition and one of the world's fastest growing health problems. The onset of T2DM is gradual, with most individuals progressing through a state of pre-dia...
Detailed Description
Type 2 diabetes (T2DM) is a major global health issue and the cost to community is high and escalating. The Asia-Pacific region carries a high disease burden, with more than 60% of the global diabetic...
Eligibility Criteria
Inclusion
- Individuals aged 40 - 60 years old
- Overweight (BMI ≥ 23kg/m2) or obese (BMI ≥ 25 kg/m2)
- With at least one blood test result showing IGT (7.8-11.0 mmol/L after a two-hour glucose tolerance test), IFG (fasting glucose 5.6 - 6.9 mmol/L) or impaired HbA1c 5.7% - 6.4%
- Owns a smartphone
- Able to read Chinese and speak Cantonese.
Exclusion
- With current or clinical history of T2DM, or with co-morbid conditions that may limit participation in the study, such as recent history of an acute cardiovascular event, uncontrolled hypertension, cancer or major psychiatric or cognitive problems
- Already participating in a weight loss programme
- Receiving drug treatment for pre-diabetes or long-term use of medicines known to influence glucose metabolism (e.g. corticosteroids)
Key Trial Info
Start Date :
June 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 31 2024
Estimated Enrollment :
282 Patients enrolled
Trial Details
Trial ID
NCT04875780
Start Date
June 1 2021
End Date
May 31 2024
Last Update
October 25 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Hong Kong
Hong Kong, Hong Kong